Yawen Xu Selected Research

sintilimab

1/2022

Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting-A Multi-Center Observational Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yawen Xu Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 05/2012
9	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 10/2012
3	Infections 01/2023 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2022
3	Neoplasm Metastasis (Metastasis) 03/2017 - 05/2012
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 05/2012
2	Infarction (Infarctions) 01/2023 - 01/2021
2	Disease Progression 01/2022 - 01/2022
2	Leukemia 01/2020 - 01/2017
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2018 - 10/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2017 - 02/2012
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Breast Cancer Lymphedema 01/2024
1	Cognitive Dysfunction 10/2023
1	Thrombosis (Thrombus) 01/2023
1	COVID-19 01/2023
1	Breakthrough Infections 01/2023
1	Cholangiocarcinoma 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Cerebral Infarction 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Macrophage Activation Syndrome 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Genetic Translocation (Chromosomal Translocation) 01/2020
1	Acute Promyelocytic Leukemia 01/2020
1	Insulin Resistance 11/2019
1	Type 2 Diabetes Mellitus (MODY) 02/2019
1	Hyperplasia 01/2018
1	Urinary Retention 01/2018
1	Carcinogenesis 01/2016
1	Urinary Calculi (Urinary Calculus) 11/2013
1	Hemorrhage 10/2013
1	Pathologic Constriction (Stenosis) 03/2013

Drug/Important Bio-Agent (IBA)

4	Docetaxel (Taxotere)FDA Link 03/2023 - 10/2012
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2013
3	lenvatinibIBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2023 - 03/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 01/2018
2	lycorineIBA 03/2017 - 01/2017
2	AlkaloidsIBA 03/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 03/2017 - 05/2012
2	Small Interfering RNA (siRNA)IBA 11/2015 - 01/2013
1	hydroxide ionIBA 10/2023
1	CateninsIBA 03/2023
1	Long Noncoding RNAIBA 03/2023
1	HomocysteineIBA 01/2023
1	VaccinesIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	camrelizumabIBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	thiamine triphosphorate (TTP)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	sintilimabIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	3-iodo-4-azido-N-hexadecylsalicylamideIBA 01/2021
1	Corn Oil (Oil, Corn)IBA 01/2021
1	benzimidazoleIBA 01/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Photosensitizing Agents (Photosensitizers)IBA 01/2019
1	triphenylphosphoniumIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	Growth InhibitorsIBA 03/2017
1	LuciferinsIBA 03/2017
1	Immune Checkpoint InhibitorsIBA 03/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	napabucasinIBA 01/2016
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2016
1	MethyltransferasesIBA 11/2015
1	DNA Methyltransferase 3BIBA 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 11/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 07/2013
1	Androgen Receptors (Androgen Receptor)IBA 10/2012
1	AndrogensIBA 10/2012

Therapy/Procedure

9	Therapeutics 01/2024 - 01/2016
2	Aftercare (After-Treatment) 01/2022 - 01/2021
1	Moxibustion 01/2024
1	Drug Therapy (Chemotherapy) 01/2021
1	Intraperitoneal Injections 01/2019
1	Eye Enucleation (Enucleation, Eye) 07/2018
1	Transurethral Resection of Prostate (TURP) 01/2018
1	Ligation 03/2017
1	Castration 01/2016
1	Radiotherapy 03/2015
1	Local Anesthesia 11/2013
1	Percutaneous Nephrolithotomy 11/2013
1	Semiconductor Lasers 10/2013
1	Catheters 10/2013
1	Stents 03/2013
1	Replantation 03/2013